MARRONE BIO INNOVATIONS INC's ticker is MBII and the CUSIP is 57165B106. A total of 23 filers reported holding MARRONE BIO INNOVATIONS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $7,000 | -63.2% | 6,221 | -75.5% | 0.00% | – |
| Q4 2021 | $19,000 | +58.3% | 25,347 | +101.8% | 0.00% | – |
| Q3 2021 | $12,000 | +9.1% | 12,562 | +83.1% | 0.00% | – |
| Q2 2021 | $11,000 | -8.3% | 6,861 | +15.3% | 0.00% | – |
| Q1 2021 | $12,000 | +100.0% | 5,948 | +28.0% | 0.00% | – |
| Q4 2020 | $6,000 | – | 4,648 | +5936.4% | 0.00% | – |
| Q3 2020 | $0 | – | 77 | -82.5% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 441 | -87.4% | 0.00% | – |
| Q1 2020 | $3,000 | 0.0% | 3,506 | +102.1% | 0.00% | – |
| Q3 2018 | $3,000 | – | 1,735 | +2698.4% | 0.00% | – |
| Q2 2018 | $0 | – | 62 | +342.9% | 0.00% | – |
| Q4 2017 | $0 | – | 14 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | -100.0% | 14 | -95.1% | 0.00% | – |
| Q3 2015 | $1,000 | 0.0% | 287 | 0.0% | 0.00% | – |
| Q2 2015 | $1,000 | – | 287 | +341.5% | 0.00% | – |
| Q1 2015 | $0 | -100.0% | 65 | -67.5% | 0.00% | – |
| Q3 2013 | $3,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARDSLEY ADVISORY PARTNERS LP | 16,692,753 | $27,877,000 | 3.39% |
| Fairpointe Capital LLC | 661,100 | $1,382,000 | 2.08% |
| WADDELL & REED FINANCIAL INC | 23,445,757 | $49,002,000 | 0.10% |
| Mesirow Financial Investment Management, Inc. | 6,618 | $14,000 | 0.04% |
| IndexIQ Advisors LLC | 224,224 | $469,000 | 0.02% |
| Clear Harbor Asset Management, LLC | 59,954 | $125,000 | 0.02% |
| Financial Advocates Investment Management | 65,310 | $137,000 | 0.01% |
| Penserra Capital Management LLC | 239,844 | $501,000 | 0.01% |
| WEXFORD CAPITAL LP | 18,828 | $39,000 | 0.01% |
| Virtu Financial LLC | 41,944 | $88,000 | 0.01% |